The global burden of early‐onset type 2 diabetes (1990–2050): An age–period–cohort analysis of incidence, disparities, and projections

Authors:

Abstract
Background: Early‐onset type 2 diabetes mellitus ( T2DM ), diagnosed between 15 and 39 years of age, poses a major public health challenge worldwide. Using data from the Global Burden of Disease Study ( GBD ) 2021, this study aimed to comprehensively assess its global burden, trends, and inequalities from 1990 to 2021, and to project the future burden to 2050. Methods: We analysed age‐standardised incidence ( ASIR ), prevalence ( ASPR ), mortality ( ASMR ), and disability‐adjusted life years ( ASDR ) rates across 204 countries. Analyses included trend analysis, socioeconomic inequality assessment, decomposition, frontier analysis, risk factor analysis, and Bayesian modelling for projections. Results: Between 1990 and 2021, global prevalent cases increased by 222.32%. ASIR , ASPR , and ASDR all rose significantly, with estimated annual percentage changes ( EAPCs ) of 2.45, 2.85, and 2.10, respectively. The burden peaked in middle‐sociodemographic index ( SDI ) regions and South/East Asia, while Oceania had the highest ASRs . The 35–39‐year age group and males bore the highest burden. Socioeconomic inequalities widened, with a 35% increase in mortality disparity affecting low‐income populations. Epidemiological changes were the primary driver of increased incidence and DALYs . High BMI accounted for 44.7%–69.2% of attributable DALYs . We project ASIR will rise to 529.52 per 100 000 by 2050, with 17.14 million new cases. Conclusions: The global burden of early‐onset T2DM rose markedly over the past three decades, with distinct disparities. Persistent inequalities, the dominant role of high BMI , and projected increases highlight an urgent need for targeted prevention in younger populations and high‐risk groups.

This publication has 19 references indexed in Scilit: